Monte Rosa Therapeutics, Inc.
NASDAQMonte Rosa Therapeutics reports Q1 results on May 8 with short sellers sitting at their most aggressive in months — and the stock priced well below where the Street sees fair value. The short interest story here is the headline. Bears control roughly 27.6% of the free float, up sharply from 17–18% just six weeks ago in late March. That jump of nearly 10 percentage points in SI % FF…
Snapshot as of 7 May 2026
Monte Rosa Therapeutics reports Q1 results on May 8 with short sellers sitting at their most aggressive in months — and the stock priced well below where the Street sees fair value. The short interest story here is the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for GLUE — free to start on ORTEX.
Sign up for free →Open GLUE on ORTEX